← Back to Clinical Trials
Recruiting NCT06759194

NCT06759194 HoLEP vs BipolEP in Management of BPH Patients With Large Prostates

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06759194
Status Recruiting
Phase
Sponsor Assiut University
Condition Benign Prostatic Hyperplasia
Study Type INTERVENTIONAL
Enrollment 98 participants
Start Date 2025-01-01
Primary Completion 2026-06-01

Trial Parameters

Condition Benign Prostatic Hyperplasia
Sponsor Assiut University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 98
Sex MALE
Min Age 50 Years
Max Age N/A
Start Date 2025-01-01
Completion 2026-06-01
Interventions
Holmium Laser Enucleation of the ProstateBipolar Enucleation of the Prostate

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is a non-inferiority prospective randomized comparative clinical trial aiming to prove the non-inferiority of bipolar enucleation of the prostate in comparison to holmium laser enucleation of the prostate in management of benign prostatic hyperplasia patients with large prostates and in turn its feasibility as an alternative procedure in hospitals with limited resources

Eligibility Criteria

Inclusion Criteria: * Age \>50 years * Prostate volume \>80 ml * Failure of or noncompliance with medical treatment * IPSS \>15 * Qmax \<15 ml/sec * Urinary retention and fixed catheters with poor results on trial of voiding without catheter Exclusion Criteria: * Patients with active UTI * Prostate cancer * Bladder carcinoma * Urethral stricture * Neurogenic bladder disorders * Redo cases

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology